WeightWatchers announced on Monday its collaboration with Amazon to distribute medications such as injectable GLP-1 obesity treatments to its members. This partnership led to a 9% increase in the telehealth provider’s shares, as investors anticipated financial gains from facilitating prescription fulfillment.
WeightWatchers clients can now confirm medication availability and arrange more efficient delivery of refrigerated drugs using the Amazon Pharmacy feature on the WeightWatchers website, said COO Jon Volkmann. The company, alternatively known as WW International, emerged from bankruptcy in July with a plan to vie for online weight-loss clients, sans debt. The announcement of the collaboration led to a surge of over 9% in the company shares, reaching $29.39 by the afternoon.
While competitors concentrated on compounded replicas of Wegovy from Novo Nordisk and Zepbound from Eli Lilly, WeightWatchers chose to align with branded drugs. They announced a collaboration with Novo to supply Wegovy to cash-paying clients through NovoCare and its partner, CenterWell Pharmacy. The company assured that it would still allow clients to fill prescriptions through other pharmacies.
Demand for GLP-1 obesity treatments skyrocketed following clinical trials that demonstrated their effectiveness, helping individuals lose around 15% of their body weight by inducing a feeling of fullness. In 2022, the US Food and Drug Administration reported a shortage of these drugs, creating difficulties for rural WeightWatchers customers to access them through physical pharmacies.
Despite an abundance of both drugs, Amazon stated that access remains a challenge in rural regions. “With GLP-1s specifically, there’s been an issue with people hopping from one pharmacy to another, searching for these drugs,” said Tanvi Patel, a VP at Amazon Pharmacy.
Amazon recently launched kiosks at some of its One Medical clinics, allowing patients to pick up common prescriptions. Although Amazon delivers GLP-1s by mail, drugs requiring cold storage will not be available in the kiosks.
The e-commerce giant’s commitment to quick delivery, particularly for perishable items, has enabled Amazon to maintain appropriate temperatures for GLP-1 shipments nationwide, Patel added. Amazon has been delivering GLP-1s to patients since 2020. Amazon Prime subscribers can expect to receive their medications within one to two days, while non-Prime members may anticipate an average four-day delivery time, though actual delivery often occurs more quickly.
In June, Amazon announced plans to extend same-day and next-day delivery to 4000 additional locations by year-end, focusing on small towns and rural areas. The company also intends to invest over US$4 billion to triple its delivery operations by 2026.
What is the partnership between WeightWatchers and Amazon?
WeightWatchers has partnered with Amazon to facilitate the delivery of medications, including injectable GLP-1 obesity treatments, to its members via Amazon Pharmacy.
What impact has the partnership had on WeightWatchers’ shares?
Following the announcement of the partnership, WeightWatchers saw a 9% increase in its shares, suggesting investor optimism about the financial benefits of the collaboration.
What measures is Amazon taking to improve medication access in rural areas?
Amazon has plans to expand same-day and next-day delivery, especially focusing on rural areas. The company has also begun setting up kiosks at some of its One Medical clinics for patients to collect common prescriptions.
